NCT05885698Recruiting
MYLUNG Consortium Part 3: Observational Study
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 7500 (estimated)
- First submitted
- 22 Feb 2023
- Start date
- 30 Jan 2023
- Primary completion date
- Dec 2030
- Lead sponsor
- US Oncology Research
- Diseases
- Lung cancer
- NCT number
- NCT05885698
What you commit to
- Study type: Observational
- Planned participants: 7500
- From 30 Jan 2023 to the primary completion date, Dec 2030
- 17 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects with small cell lung cancer
Other
- Stage IA at the time of enrollment
- Subjects with Unknown primary tumor origin
Who the study is looking for
- Adult subjects (18 years and older) with newly diagnosed early stage, locally advanced or metastatic non-small cell lung cancer
- Must be eligible for systemic therapy based on the treating provider's assessment. If systemic therapy was recommended and documented by the treating provider but the patient declined, they can still be eligible for the study. Patients can be enrolled prior to start of treatment.
- Subjects who developed locally advanced or metastatic disease after receiving adjuvant or neoadjuvant therapy are eligible if the adjuvant/neoadjuvant therapy was completed at least 12 months prior to the development of locally advanced or metastatic disease
- Subjects must be enrolled within 30 days of initiation of systemic therapy
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (17)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| New York Oncology Hematology, P.C. Coordinator of this site? Confirm its status | Albany | United States | Recruiting |
| Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Coordinator of this site? Confirm its status | Blacksburg | United States | Recruiting |
| Affiliated Oncologists, LLC Coordinator of this site? Confirm its status | Chicago Ridge | United States | Recruiting |
| Oncology Hematology Care Clinical Trials LLC Coordinator of this site? Confirm its status | Cincinnati | United States | Recruiting |
| Southern Cancer Center Pc Coordinator of this site? Confirm its status | Daphne | United States | Recruiting |
| Rocky Mountain Cancer Center Coordinator of this site? Confirm its status | Denver | United States | Active, not recruiting |
| Willamette Valley Cancer Institute and Research Center Coordinator of this site? Confirm its status | Eugene | United States | Recruiting |
| Virginia Cancer Specialists PC Coordinator of this site? Confirm its status | Fairfax | United States | Active, not recruiting |
| Minnesota Oncology Hematology, P.A. Coordinator of this site? Confirm its status | Minneapolis | United States | Active, not recruiting |
| Virginia Oncology Associates Coordinator of this site? Confirm its status | Newport News | United States | Recruiting |
| Illinois Cancer Specialists Coordinator of this site? Confirm its status | Niles | United States | Active, not recruiting |
| Cancer Care Centers of Brevard, Inc. Coordinator of this site? Confirm its status | Palm Bay | United States | Recruiting |
| Woodlands Medical Specialists, PA Coordinator of this site? Confirm its status | Pensacola | United States | Active, not recruiting |
| Arizona Oncology Associates, PC - NAHOA Coordinator of this site? Confirm its status | Prescott Valley | United States | Not yet recruiting |
| Maryland Oncology Hematology P.A. Coordinator of this site? Confirm its status | Silver Spring | United States | Active, not recruiting |
| Northwest Cancer Specialists, P.C. Coordinator of this site? Confirm its status | Vancouver | United States | Recruiting |
| Shenandoah Oncology, P.C. Coordinator of this site? Confirm its status | Winchester | United States | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.